I am incredibly honored and excited to serve @MayoMN_IMRES! @AmyOxentenkoMD (my former #CMR!) has been an amazing #PD and I hope to carry on her advocacy, innovation, & empathy. Residents, thank you for the warm welcome! And to my @MayoHemeOnc fellows, I will miss you dearly.
Congratulations to our newly selected Mayo Clinic Internal Medicine Residency Program Director Dr. Carrie Thompson! Dr. Thompson is a consultant in Hematology, and she will transition from her role as a program director for Mayo RST Heme/Onc fellowship.
@CaThompsonMD
Just out in the New England Journal of Medicine!
Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance @NEJM https://t.co/7dza0YrFh5
5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS. Lots of Tables and Figures. Bookmark!
How to test and manage patients. Who needs bone marrow exams and scans. It’s all in here!
MGUS is important not just because it’s a precursor to multiple myeloma. It causes a lot of other problems. Learn all about MGUS, and the various terms you hear MGCS, MGRS etc. in this Review
@myelomaMD and I have tried to keep every sentence in this Review simple and easy to follow. #MGUSVR
#Hematology Patient-Reported Outcomes (PROs) vs Clinician-Reported Adverse Events in a large #lymphoma trial: finding from the POLARIX trials in 1L large B-cell lymphoma #lymsm#VBHC
https://t.co/hPv6JRUI7y
PROs vs clinician-reported adverse events in the POLARIX study: we are insufficiently capturing patient experience with conventional toxicity assessments. Great collaboration with Dr. Carrie Thompson @MayoClinic@WilmotCancer
https://t.co/7CLML0PkQi
Patient-reported outcomes, such as higher health status and lower symptom burden, are independently associated with improved overall survival in cancer patients. https://t.co/3GSlpDITsJ @RSTHuang
#WIM Last night, our Women In Medicine Group held an amazing event with round table discussions for residents and women leaders in Medicine! We were fortunate enough to have our PD, APDs, Rotation Director, and ACG President/ Vice Dean of Practice for Mayo Clinic in attendance!
Congratulations to the next generation of physicians who matched to residency programs today at Mayo Clinic and across the nation. I hope you’ll continue to embrace the opportunities ahead as you shape the future of patient care. #Match2025
@BThilagarMD@CStephenson_MD I’ve never had that happen during a presentation before! Everyone had to evacuate the room. Does that mean that my talk was 🔥🔥!? 🤣
Great talk on anemia by @CaThompsonMD at #STIM2025
* Please don’t check folate 😉
* Zn supplement causes secondary Cu deficiency
* When end of talk questions come pull the fire alarm 😜 @CStephenson_MD
#MayoIDGrandRounds@MayoMN_IMRES presented cases with unusual clinical syndromes due to
1.Rickettsia felis
2.Coxiella burnetii
3.Cardiobacterium hominis
Plus a case of persistent MRSA bacteremia
Lots of clinical pearls and learning this morning! @Slalvarezm
😀😍😎🥺🤗
Our emoji PRO paper is published! Will this change the way that we collect patient reported outcomes in hematology and oncology? 🤔
@MayoHemeOnc@MayoCancerCare
Please select the one emoji that best represents your feeling towards our research paper developing emoji scales for assessing #patientreportedoutcomes: 😩 ☹️ 😐 🙂 😄 @CaThompsonMD https://t.co/fv8KHv38jy
Please select the one emoji that best represents your feeling towards our research paper developing emoji scales for assessing #patientreportedoutcomes: 😩 ☹️ 😐 🙂 😄 @CaThompsonMD https://t.co/fv8KHv38jy
We are seeking a lymphoma investigator to join our Lymphoid Malignancies Disease Group at @MayoClinic in Rochester, MN. Join @GregNowakowski, Steve Ansell, @WitzigLab and may other talented individuals to advance lymphoma care and research. https://t.co/tlKACrH7sR